CD8型
过继性细胞移植
癌症研究
细胞毒性T细胞
血管生成
穿孔素
干扰素γ
浆细胞瘤
免疫疗法
T细胞
免疫学
生物
医学
细胞因子
免疫系统
多发性骨髓瘤
体外
生物化学
作者
Zhihai Qin,Johannes Schwartzkopff,Felicia Pradera,Thomas Kammertoens,Barbara Seliger,Hanspeter Pircher,Thomas Blankenstein
出处
期刊:PubMed
日期:2003-07-15
卷期号:63 (14): 4095-100
被引量:227
摘要
It is thought that tumor rejection by CD8(+) T-cell effectors is primarily mediated by direct killing. We show that rejection of different tumors (fibrosarcoma, ras-transformed fibroblasts, colon carcinoma, and plasmacytoma) by CD8(+) T cells is always preceded by inhibition of tumor-induced angiogenesis. Angiostasis and tumor rejection were observed in perforin but not in IFN-gamma-deficient mice. Furthermore, adoptive transfer of tumor-specific CD8(+) T cells from IFN-gamma-competent mice inhibited angiogenesis of lung metastases in comparison to those from IFN-gamma gene-deficient mice. Taken together with our previous findings, we conclude that IFN-gamma-dependent antiangiogenesis is a general mechanism involved in tumor rejection by CD4(+) and CD8(+) T-cell effectors.
科研通智能强力驱动
Strongly Powered by AbleSci AI